Lipancrea Lipazy

Amylase, Lipase, Protease, the active ingredients in Lipancrea Lipazy, is a pancreatic enzyme preparation presented as an oral dosage form for oral use. It aids the digestion of carbohydrates, fats and proteins in patients with exocrine pancreatic insufficiency. GNH USA supplies Lipancrea Lipazy as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lipancrea Lipazy provides exogenous pancreatic enzymes to support digestion in conditions characterized by enzyme deficiency. - Exocrine pancreatic insufficiency: improves nutrient absorption and reduces steatorrhea. - Cystic fibrosis‑related pancreatic insufficiency: assists in maintaining caloric intake and growth. - Chronic pancreatitis: alleviates maldigestion symptoms and supports weight maintenance. - Post‑pancreatic surgery: compensates for loss of endogenous enzyme production.

Lipancrea Lipazy may be associated with gastrointestinal and allergic reactions.

Common Side Effects: - Abdominal discomfort or pain - Flatulence or bloating - Diarrhea or loose stools - Nausea or mild vomiting - Constipation - Oily or greasy stools (steatorrhea)

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Fibrosing colonopathy (rare intestinal fibrosis) - Acute pancreatitis - Persistent abdominal pain requiring medical evaluation

Before initiating therapy, consider patient‑specific factors and monitor for adverse events. - Assess pancreatic insufficiency: confirm diagnosis prior to use. - Monitor for allergic reactions: discontinue if rash, itching or swelling occurs. - Adjust dose based on clinical response and nutritional status. - Avoid concurrent use of antacids containing aluminum or magnesium that may inactivate enzymes. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Enzyme activity can be altered by certain medications, requiring attention to co‑administration.

Major Interactions (Avoid): - Proton pump inhibitors: may reduce enzyme activation in the stomach. - Antacids with aluminum or magnesium: can bind enzymes and diminish efficacy.

Moderate Interactions (Monitor Closely): - Oral contraceptives: potential alteration in hormone absorption. - Warfarin: monitor INR as gastrointestinal changes may affect vitamin K status. - Corticosteroids: may increase risk of gastrointestinal irritation.